ArticleSocial psychiatry and psychiatric epidemiology2026
Patterns of substance-induced psychosis during the COVID-19 pandemic: a national registry study of specialist healthcare contacts.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe COVID-19 pandemic affected both substance use patterns and impacted healthcare systems. Substance-induced psychosis (SIP) is a severe mental disorder characterized by severe psychosis triggered by substance use. The number of treated SIP episodes may be sensitive to both changes in substance availability and treatment access. We study investigated whether the monthly prevalence of SIP episodes and mortality among SIP patients changed during the pandemic in Norway, comparing observed cases during 2020-2021 to predictions based on pre-pandemic trends.
methodsWe analyzed data from the Norwegian Patient Registry (2012-2021), we identified 7,150 individuals diagnosed with SIP (ICD-10 F1x.5). Monthly prevalence rates for overall SIP episodes and substance-specific SIP diagnoses (i.e., due to alcohol, cannabis, amphetamines, or multiple substances) and yearly mortality rates were predicted using ensemble time-series models. Deviations during the pandemic were assessed against 95% prediction intervals derived from pre-pandemic data.
resultsThe observed monthly prevalence of episodes of any SIP during 2020-2021 largely matched predictions, with some deviations. Alcohol-induced psychosis showed lower than expected rates in 2020 but higher in 2021. Cannabis-induced psychosis rates were below expectations. Amphetamine-induced psychosis and psychosis due to multiple substances showed higher-than-expected rates during lockdowns, with lower rates between lockdowns. Mortality rates among SIP patients for all-cause mortality, suicide, and accidental poisoning during the pandemic were similar to those in the pre-pandemic period.
conclusionsThe pandemic did not seem to alter the overall number of SIP episodes. There were, however, some drug-specific changes. This may reflect drug availability, changes in substance use, or changes in healthcare access. A high mortality burden was observed among patients with SIP. However, mortality rates due to all causes, suicide, and accidental poisoning in this group were similar in the pandemic and pre-pandemic periods.
Indexed as
Identifiers
42223648What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.